4133.TW
Price:
$22.9
Market Cap:
$1.39B
Abnova (Taiwan) Corporation manufactures and sells various recombinant proteins and antibodies. The company's products portfolio includes SARS-CoV/CoV-2, DNA and RNA, proteins/peptides, DNAxPab, beads/dyes, lysates/slides, antibody pairs/kits, antibody and tissue arrays, in situ hybridization products, systems and automations, GMP and analyte specific reagents, and in vitro diagnostics. It also provides MaxPab, monoclonal, polyclonal, recombinant, conjugate, secondary/tag, IHC/pathology, and circulating rare cell antibodies. In addition, the company offers integrated solutions and services, including gene synthesis and cytogenetics; peptide services, protein expression, and conjugations; ant...[Read more]
Industry
Biotechnology
IPO Date
2009-12-28
Stock Exchange
TAI
Ticker
4133.TW
According to Abnova (Taiwan) Corporation’s latest financial reports and current stock price. The company's current PE Ratio is 572.50. This represents a change of 2.48% compared to the average of 22.22 of the last 4 quarters.
The mean historical PE Ratio of Abnova (Taiwan) Corporation over the last ten years is 93.33. The current 572.50 PE Ratio has changed 61.24% with respect to the historical average. Over the past ten years (40 quarters), 4133.TW's PE Ratio was at its highest in in the September 2019 quarter at 711.25. The PE Ratio was at its lowest in in the December 2021 quarter at -455.47.
Average
93.33
Median
41.80
Minimum
29.14
Maximum
471.37
Discovering the peaks and valleys of Abnova (Taiwan) Corporation PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 1.13%
Maximum Annual PE Ratio = 471.37
Minimum Annual Increase = -79.53%
Minimum Annual PE Ratio = 29.14
| Year | PE Ratio | Change |
|---|---|---|
| 2024 | 29.14 | -40.22% |
| 2023 | 48.75 | 46.25% |
| 2022 | 33.33 | -64.14% |
| 2021 | 92.96 | -3.66% |
| 2020 | 96.49 | -79.53% |
| 2019 | 471.37 | 1.13% |
| 2018 | 38.47 | -4.68% |
| 2017 | 40.36 | 3.01% |
| 2016 | 39.18 | -9.41% |
| 2015 | 43.25 | 40.24% |
The current PE Ratio of Abnova (Taiwan) Corporation (4133.TW) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
37.08
5-year avg
60.13
10-year avg
93.33
Abnova (Taiwan) Corporation’s PE Ratio is greater than NaviFUS Corp. (-12.06), greater than Enimmune corporation (-7.20), greater than BiOptic Inc. (62.08), greater than GenMont Biotech Incorporation (45.03), greater than GeneReach Biotechnology Corp. (-7.44), greater than Great Novel Therapeutics Biotech & Medicals (-17.23), greater than Meribank Biotech Co., Ltd (-20.99), greater than NeoCore Technology Co., Ltd. (-77.59), greater than MegaPro Biomedical Co., Ltd (-5.45), greater than Taiwan Advance Bio-Pharmaceutical Inc. (42.32),
| Company | PE Ratio | Market cap |
|---|---|---|
| -12.06 | $1.48B | |
| -7.20 | $1.51B | |
| 62.08 | $1.37B | |
| 45.03 | $1.57B | |
| -7.44 | $1.12B | |
| -17.23 | $1.51B | |
| -20.99 | $1.53B | |
| -77.59 | $1.58B | |
| -5.45 | $990.07M | |
| 42.32 | $990.00M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Abnova (Taiwan) Corporation using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Abnova (Taiwan) Corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Abnova (Taiwan) Corporation's PE Ratio?
How is the PE Ratio calculated for Abnova (Taiwan) Corporation (4133.TW)?
What is the highest PE Ratio for Abnova (Taiwan) Corporation (4133.TW)?
What is the 3-year average PE Ratio for Abnova (Taiwan) Corporation (4133.TW)?
What is the 5-year average PE Ratio for Abnova (Taiwan) Corporation (4133.TW)?
How does the current PE Ratio for Abnova (Taiwan) Corporation (4133.TW) compare to its historical average?